Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Gallus gallus (chicken) | |
Drosophila melanogaster (fruit fly) | |
Homo sapiens (human) | |
Viruses |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
FUT11 | GDP-Fuc |
|
R |
|
R | |
FUT10 | GDP-Fuc |
|
R |
|
R | |
MGAT3 | UDP-GlcNAc |
|
Asn-X |
|
Asn-X | |
MGAT4A | UDP-GlcNAc |
|
PA |
|
PA | |
MGAT2 | UDP-GlcNAc |
|
Asn-Xaa |
|
Asn-Xaa |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
FUT8 | GDP-Fuc |
|
Free |
|
Free | |
FUT11 | GDP-Fuc |
|
R |
|
R | |
FUT10 | GDP-Fuc |
|
R |
|
R | |
MGAT3 | UDP-GlcNAc |
|
Asn-X |
|
Asn-X | |
MGAT4A | UDP-GlcNAc |
|
[beta]1-Asn |
|
[beta]1-Asn |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
O75015 | Low affinity immunoglobulin gamma Fc region receptor III-B | ||
P01012 | Ovalbumin | ||
P01579 | Interferon gamma | ||
P01857 | Immunoglobulin heavy constant gamma 1 | ||
P01859 | Immunoglobulin heavy constant gamma 2 | ||
P01860 | Immunoglobulin heavy constant gamma 3 | ||
P01861 | Immunoglobulin heavy constant gamma 4 | ||
P01876 | Immunoglobulin heavy constant alpha 1 | ||
P01877 | Immunoglobulin heavy constant alpha 2 | ||
P02710 | Acetylcholine receptor subunit alpha |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl 3b:b-dglc-HEX-1:5 4s:n-acetyl 5b:b-dman-HEX-1:5 6b:a-dman-HEX-1:5 7b:b-dglc-HEX-1:5 8s:n-acetyl 9b:a-dman-HEX-1:5 10b:b-dglc-HEX-1:5 11s:n-acetyl LIN 1:1d(2+1)2n 2:1o(4+1)3d 3:3d(2+1)4n 4:3o(4+1)5d 5:5o(3+1)6d 6:6o(2+1)7d 7:7d(2+1)8n 8:5o(6+1)9d 9:9o(2+1)10d 10:10d(2+1)11n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
34834161 | Glycan Profile Analysis of Engineered Trastuzumab with Rationally Added Glycosylation Sequons Presents Significantly Increased Glycan Complexity | Cruz E | 2021 Oct 20 |
|
34207636 | What Can N-glycomics and N-glycoproteomics of Cerebrospinal Fluid Tell Us about Alzheimer Disease? | Gaunitz S | 2021 Jun 9 |
|
34106099 | N-Glycosylation in isolated rat nerve terminals | Matthies I | 2021 Aug 1 |
|
33139572 | Spatial and temporal diversity of glycome expression in mammalian brain | Lee Jua | 2020-11-17 |
|
31889402 | Glycan biomarkers for Alzheimer disease correlate with T-tau and P-tau in cerebrospinal fluid in subjective cognitive impairment | Schedin-Weiss Sophia | 2020-08 |
|
32841605 | Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor | Zhao P | 2020 Oct 07 |
|
32080177 | Structural basis for substrate specificity and catalysis of α1,6-fucosyltransferase | García-García A | 2020 Feb 20 |
|
29671580 | Site-Specific Profiling of Serum Glycoproteins Using N-Linked Glycan and Glycosite Analysis Revealing Atypical N-Glycosylation Sites on Albumin and alpha-1B-Glycoprotein | Sun S | 2018 Apr 19 |
|
26595420 | Structure of full-length human anti-PD1 therapeutic IgG4 antibody pembrolizumab | Scapin G | 2015 Nov 23 |
|
25345863 | Fc Gamma Receptor Glycosylation Modulates the Binding of IgG Glycoforms: A Requirement for Stable Antibody Interactions | Hayes JM | 2014 Nov 11 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025